KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Encompass Health (EHC) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $175.0 million.

  • Encompass Health's Profit After Tax rose 1840.32% to $175.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $721.6 million, marking a year-over-year increase of 2812.5%. This contributed to the annual value of $599.4 million for FY2024, which is 2618.95% up from last year.
  • Latest data reveals that Encompass Health reported Profit After Tax of $175.0 million as of Q3 2025, which was up 1840.32% from $185.8 million recorded in Q2 2025.
  • Encompass Health's Profit After Tax's 5-year high stood at $197.0 million during Q1 2025, with a 5-year trough of $71.3 million in Q2 2022.
  • In the last 5 years, Encompass Health's Profit After Tax had a median value of $127.6 million in 2023 and averaged $133.4 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first soared by 19399.59% in 2021, then tumbled by 4978.87% in 2022.
  • Over the past 5 years, Encompass Health's Profit After Tax (Quarter) stood at $115.7 million in 2021, then grew by 2.85% to $119.0 million in 2022, then rose by 7.23% to $127.6 million in 2023, then rose by 28.37% to $163.8 million in 2024, then grew by 6.84% to $175.0 million in 2025.
  • Its last three reported values are $175.0 million in Q3 2025, $185.8 million for Q2 2025, and $197.0 million during Q1 2025.